atossa stock forecast 2025

link.addEventListener('click', Financial commentators are providing bullish 2025 price forecasts. Your current $100 investment may be up to $350.94 in 2025. Privacy Notice, Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. The 1-12 reverse split was announced on Friday, April 20th 2018. Upgrade to remove this ad, 20 Period Moving Average (Increase Horizon). Max Forecast . Atossa Therapeutics Announces Two-Year Update of FDA-Approved Expanded Access Treatment with Endoxifen. The most recent target from analysts at Opennheimer set the price target at $125 a share, the highest target to date. tops stock forecast 2025. var link = manageCookies.querySelector('.link'); Quote Stock Analysis News Price vs Fair Value Trailing Returns … $6.00 +60.43%. } News for Atossa Therapeutics Inc. Thursday, February 11, 2021. Atossa Therapeutics Inc Stock Forecast, Predictions & Price Target Add to Watchlist. Investors can use this forecasting interface to forecast Atossa Genetics historical stock prices and determine the direction of Atossa Genetics's future trends based on various well-known forecasting models. This stock … $5.00 +33.69%. Atossa Therapeutics's stock reverse split before market open on Friday, April 20th 2018. 2021-2025 NASDAQ:ADBE Adobe stock price forecast, Buy, Target 702 (+40.44%) Get link; Facebook; Twitter; Pinterest; Email; Other Apps; Sunday, December 27, 2020 Adobe (NASDAQ: ADBE) Trade : Buy Entry : 499.86 Target : 702 (202.14, +40.44%) Stop : 438 (-61.86, -12.38%) Posted on Sunday, December 27, 2020 Note : There seems to be not many people interested in this stock. The one-year Atossa Therapeutics Inc. stock forecast points to a potential upside of 41.76. Intraday data delayed at least 15 minutes or per exchange requirements. An investor that had 100 shares of Atossa Therapeutics stock prior to the reverse split would have 8 shares …

As of 2020 November 05, Thursday current price of PTON stock is 111.650$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). $7.00 +87.17%. AC Investment Inc. delivers AI check for Credit Rating, rating, news, stock, financials, financial information, fund, dividend, price forecast. In turn, he expects Tesla to produce more than 2 million electric vehicles and $15 in earnings-per-share by 2025. Turning out attention to how the Atossa Therapeutics, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: ATOS’s stock is -4.4% on the day and +152.17% in the past 12 months, while Thermo Fisher Scientific Inc (TMO) traded -1.53% in the last session and was positioned +47.43% up on its price 12 months ago. cursor: pointer; Columbia Sportswear Co - COLM Get email alerts Feb. 9, 2021 SELL. var manageCookies = document.getElementById('manage-cookies'); Another comparison … Across the board of Wallstreet analysts the average 12 month price target is $79.08 a share. As of 2021 February 11, Thursday current price of ATOS stock is 3.555$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Atossa Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Atossa Stock at $8 a Share? Intraday Data provided by FACTSET and subject to terms of use. Earnings Dividend Ownership. Atossa Therapeutics, Inc. (ATOS) estimates and forecasts if (gdprApplies) { Watch the warnings coming from the stock market’s sell signals MarketWatch. The Tesla stock forecast is … With a 5-year investment, the revenue is expected to be around +250.94%. Amazon Stock Forecast 2021, 2022, 2023. Financials. Atossa Therapeutics Inc ATOS Morningstar Rating Rating as of Feb 10, 2021. 10:47 AM ET. By using this site, you agree to the Subscriber Agreement & Terms of Use, Atossa Therapeutics, Inc. Common Stock (ATOS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Are you bullish or bearish? AMD stock predictions for November 2021. Find real-time ATOS - Atossa Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Do Not Sell My Personal Information Maximum value 89.43, while minimum 79.31. function () { window.djcmp.showConsentModal('marketwatch'); }); Boeing Stock Forecast 2021, 2022, 2023. 10:55 AM ET. associated with market volatility, economic swings, and company-specific events. This 5-Star Analyst Thinks It’s Possible . Prof. R. Jayaraman (VU2JN) A Personal blog on Academic career in Civil Engineering, Amateur Radio hobby, and other interests Menu Skip to content Get today's Atossa Genetics Inc stock price and latest ATOS news as well as Atossa Genetics real-time stock quotes, technical analysis, full financials and more. FIBK FORECASTS. Wednesday, December 18, 2019. Fastly Stock forecast for 2021 and beyond Price forecasts. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. As of 2021 February 11, Thursday current price of TTCF stock is 24.080$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Tattooed Chef, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. text-decoration: underline; 08:23 AM ET The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 19th 2018. Most of Macroaxis users are presently bullish on Atossa Genetics. color: #000066; Cookie Notice and Your Ad Choices. Atossa Therapeutics Inc. ATOS 3.31 0.17 (4.89%). Atossa Therapeutics Inc Stock Price Forecast, "ATOS" Predictons for2025 a.link { Your biggest risk in this bullish stock market is ignoring sell signals MarketWatch, Watch the warnings coming from the stock market’s sell signals MarketWatch, Atossa Genetics upgraded to buy from hold at Maxim Group MarketWatch, Estrogen Receptor Beta Market Statistics 2021 by Size, Growth, Demand, Share, Top Players, Regions, Segments, Industry Trends and 2027 Forecast Says, Industry Research Biz The Express Wire, Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Accomplishments and Strategy for 2021 GlobeNewswire, Estrogen Receptor Beta Market Size, Share, Gross Margin, Worldwide Impact of COVID-19 on Industry, Growth, Trends, Future Demand, Analysis by 2021 Top Leading Player and Forecast till 2025 The Express Wire, Atossa Therapeutics Announces Two-Year Update of FDA-Approved Expanded Access Treatment with Endoxifen GlobeNewswire, Atossa Therapeutics' Phase 2 Endoxifen Breast Cancer Study Produces Substantially Positive Results Allowing Study to be Halted Early GlobeNewswire, Atossa Therapeutics Receives $21 Million from Recent Exercises of Outstanding Warrants GlobeNewswire, New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory PR Newswire - PRF, Registration Is Now Open For Tribe Public's Webinar Event "The Important Role of COVID Therapeutics in a Post-Vaccine World" Featuring Atossa Therapeutics' CEO & CFO On February 2, 2021 GlobeNewswire, Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021 GlobeNewswire, 4 Hot Penny Stocks To Watch Before Monday's Opening Bell Penny Stocks, Copyright 2021 MarketWatch, Inc. All rights reserved. Peloton Interactive, Inc. quote is … The forecast for beginning of November 80.35. a.link:hover { Your biggest risk in this bullish stock market is ignoring sell signals MarketWatch. Atossa Therapeutics Inc Stock Price Forecast for 2025: May 2025: Open: 8.096: Close: 5.611: Min: 4.518: Max: 8.096: Change: -44.29 % Atossa Therapeutics Inc Stock Price Forecast for 2025: June 2025: Open: 5.963: Close: 6.307: Min: 5.634: Max: 6.440: Change: 5.46 % Atossa Therapeutics Inc Stock Price Forecast for 2025: July 2025: Open: 6.725: Close: 5.826: Min: 5.711 However, solely looking at the historical price movement is usually misleading. To hit the forecast high, the stock’s price needs a +111.86% upsurge from its latest level, while the stock would need to tank 41.24% for it to hit the projected low. }. Thursday, February 04, 2021. As of right now, however, the S&P 500 remains over 3400 after the summer recovery into the autumn months. About the Atossa Therapeutics, Inc. stock forecast. Avg Forecast. Atossa Therapeutics, Inc. Common Stock (ATOS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. is another major factor that has played its par SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast … Estimated Average Forecasted Pfizer Price: 49.41 Positive monthly dynamics of the instrument is expected with 8.563% volatility is expected. What is your sentiment towards investing in Atossa Genetics? Analyst price target for ATOSBased on 2 analysts offering 12 month price targets for Atossa Therapeutics Inc. Min Forecast. ATOS: Get the latest Atossa Genetics stock price and detailed information including ATOS news, historical charts and realtime prices. if (manageCookies && window.djcmp) { } AMD stock price predictions for December 2021. … Should I buy or sell ATOS stock? window.djcmp.gdprApplies('tcfapiOnly', function (gdprApplies) { Atossa Genetics Stock Forecast is based on your current time horizon. text-decoration: none; NASDAQ Updated Feb 11, 2021 6:25 PM Pessimistic forecast: 47.01 According to analyst projections, ATOS’s forecast low is $5 with $7.5 as the target high. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. With a 5-year investment, the revenue is expected to be around +84.47%. Price at the end 84.37, change for November 5.0%. The market cap for the stock reached $260.53 million, with 71.57 million shares outstanding and 71.52 million shares in the current float. Financials The Atossa Genetics Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Averaged AMD stock price for month 83.37. The average equity rating for ATOS stock is currently 2.00, trading closer to a bullish pattern in the stock market. Atossa’s stock fell by 10.16% to close the week and ended the trading session at $3.89 and a daily trading volume that doubled its average volume of 18.5 million shares. Historical and current end-of-day data provided by FACTSET. About the Tattooed Chef, Inc. stock forecast. Revenue USD Mil Gross Margin percentage Operating Income USD Mil Operating Margin percentage Net Income USD Mil Earnings Per Share USD … } Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk }); All quotes are in local exchange time. Their forecasts range from $33.00 to $160.00. Overview Forecast. Find the latest Atossa Therapeutics, Inc. (ATOS) stock quote, history, news and other vital information to help you with your stock trading and investing. Three months stock forecast Feb. 9, 2021. tsla stock forecast 2025. Your biggest risk in this bullish stock market is ignoring sell signals, Watch the warnings coming from the stock market’s sell signals, Estrogen Receptor Beta Market Statistics 2021 by Size, Growth, Demand, Share, Top Players, Regions, Segments, Industry Trends and 2027 Forecast Says, Industry Research Biz, Atossa Therapeutics President and CEO Dr. Steven C. Quay Issues Annual Letter to Stockholders Highlighting Key Accomplishments and Strategy for 2021, Estrogen Receptor Beta Market Size, Share, Gross Margin, Worldwide Impact of COVID-19 on Industry, Growth, Trends, Future Demand, Analysis by 2021 Top Leading Player and Forecast till 2025, Atossa Therapeutics Announces Two-Year Update of FDA-Approved Expanded Access Treatment with Endoxifen, Atossa Therapeutics' Phase 2 Endoxifen Breast Cancer Study Produces Substantially Positive Results Allowing Study to be Halted Early, Atossa Therapeutics Receives $21 Million from Recent Exercises of Outstanding Warrants, New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory, Registration Is Now Open For Tribe Public's Webinar Event "The Important Role of COVID Therapeutics in a Post-Vaccine World" Featuring Atossa Therapeutics' CEO & CFO On February 2, 2021, Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021, 4 Hot Penny Stocks To Watch Before Monday's Opening Bell.